Global Tracheostomy Products Market

Tracheostomy Products Market Size, Share, Growth Analysis, By Type(Tracheostomy Tubes, Ventilation Accessories, Clean & Care Kits, and Others), By Technique(Percutaneous Dilatational Tracheostomy, Surgical Tracheostomy, Demographics, Adult Patients), By End-use(Hospitals & Surgery Centers, Ambulatory Care Centers, Home Care Settings, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2624 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 94 | Figures: 76

Tracheostomy Products Market Insights

Global Tracheostomy Products Market size was valued at USD 193.8 million in 2022 and is poised to grow from USD 210 million in 2023 to USD 290 million by 2031, at a CAGR of 4.2% during the forecast period (2024-2031).

The demand for tracheostomy accessories is rising as more surgeries are performed globally. COPD is one of the top causes of death in the globe. According to the WHO, there were over 251 million COPD sufferers globally. The growing number of surgeries and medical procedures that require airway management and ventilation support boosts the demand for tracheostomy products. Tracheostomy is often performed during critical care, emergency situations, and surgical procedures, creating a consistent demand for related products.

A rise in the prevalence of COPD and a consequent rise in the need for tracheostomy care are mostly caused by an increase in cigarette use and poor air quality, especially in middle-income countries. The number of persons requiring mechanical ventilation along with additional forms of respiratory support has considerably grown as a result of the COVID-19 epidemic. Long-term mechanical breathing is required for these patients, but some of them also need tracheostomies to enable weaning and make better use of hospital resources. However, because of the creation of aerosols and the high danger of nosocomial illness to medical personnel, the tracheostomy technique is challenging to conduct. Although cutaneous tracheostomy (PCT) is the gold standard of care in many ICUs, it poses a greater risk of aerosol production.

However, the main function of tracheostomies is to facilitate weaning in COVID-19 patients. Due to rising healthcare expenses and the financial standing of nations including the U.S., China, & India, among others, market participants might anticipate attractive opportunities. Additionally, tracheostomy supplies are used in numerous tracheostomy procedures, including those treating obstructive sleep apnea, chronic lung illness, anaphylaxis, throat malignancy, diaphragm malfunction, laryngectomy, and vocal cord weakness, among other conditions. The market is anticipated to rise due to favorable reimbursement policies, a developing healthcare infrastructure, and a high prevalence of respiratory illnesses.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Tracheostomy Products Market size was valued at USD 193.8 million in 2022 and is poised to grow from USD 210 million in 2023 to USD 290 million by 2031, at a CAGR of 4.2% during the forecast period (2024-2031).

The demand for at-home care for very ill patients is increasing as a result of technological improvements. The main competitors in the market are concentrating on improving their distribution capabilities, especially in emerging markets. For instance, Smiths Medical expanded their selection of tracheostomy tubes in 2021 by adding a (PVC) tracheostomy tubing portfolio. Additionally, in 2021 Cook Medical introduced the Blue Rhino G2-Multi Percutaneous Tracheostomy Introducer Kits and Trays in the United States and Canada. 'Medtronic plc', 'Smiths Medical', 'Teleflex Incorporated', 'Cook Medical', 'Fisher & Paykel Healthcare Limited', 'C. R. Bard, Inc. (now part of BD)', 'Medline Industries, Inc.', 'ConvaTec Group PLC', 'Boston Medical Products, Inc.', 'Tracoe Medical GmbH', 'Troge Medical GmbH', 'Well Lead Medical Co., Ltd.', 'Fuji Systems Corp.', 'Pulmodyne', 'Humancare Group', 'Andreas Fahl Medizintechnik-Vertrieb GmbH', 'VBM Medizintechnik GmbH', 'Salter Labs', 'Pulmomed', 'Kapitex Healthcare Ltd.'

The rising prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), sleep apnea, and tracheal stenosis, is a significant driver for the tracheostomy products market. Tracheostomy is a common procedure performed in patients with severe respiratory conditions, creating a demand for tracheostomy products.

Growing Demand for Disposable Tracheostomy Products: There has been an increasing preference for disposable tracheostomy products due to their convenience, reduced risk of infection, and ease of use. Disposable tracheostomy tubes and related accessories offer cost-effective solutions and eliminate the need for cleaning and sterilization.

North America dominated the market in terms of revenue share in 2022 due to the region's strong healthcare infrastructure, quick development of novel treatments and technologies for throat cancer, and expanding presence of major companies. The market is expected to rise primarily a result of important factors like increased healthcare spending per person and a high prevalence of respiratory ailments. The expansion of the North American regional market is also projected to be boosted by supportive government efforts and an increase in research collaborations.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Tracheostomy Products Market

Report ID: SQMIG35A2624

$5,300
BUY NOW GET FREE SAMPLE